---
parent: Biology
layout: meth
---
# èŠæ›œå®‡

>[time=Saturday Jan, 04, 2020]
>[time=Wednesday Jan, 08, 2020]

<iframe width="500" height="150" scrolling="no" frameborder="no" allow="autoplay" src="https://w.soundcloud.com/player/?url=https%3A//api.soundcloud.com/tracks/668254808&color=%23eb734c&auto_play=false&hide_related=false&show_comments=false&show_user=true&show_reposts=false&show_teaser=false&visual=true"></iframe>

# part 1

electrophoresis é›»æ³³  
plasmids è³ªé«” = cloning vectors é¸æ®–è¼‰é«”  

## DNA cloning

 {â†’|restriction enzymes} cut ç´°èŒæ®–é«”&äººé¡DNA(ç”¨åŒä¸€å€‹) â†’ produce sticky ends {â†’|DNA ligase} bond with complementary sticky ends  
 
![[èŠæ›œå®‡-1.png]]

<!-- Fig. 20-3-3 -->

![[èŠæ›œå®‡-2.png]]

original plasmid: called <u>cloning vector</u>, å¸¶ DNAé€²å»å®¿ä¸»ç´°èƒ then replicate

<!-- Fig. 20-2 -->
![[èŠæ›œå®‡-3.png]]

genomic library: æŠŠå¾ˆå¤š DNA clone åˆ°å™¬èŒé«”è£¡

<!-- Figure 20.5 -->

![[èŠæ›œå®‡-4.png]]

bacterial artificial chromosome (BAC): 

- è¢« trimmed down çš„ å¤§è³ªé«”ï¼Œå¯ carry å¾ˆå¤š DNA  
- æœ‰ç”¨åœ¨ DNA library 

complementary DNA (cDNA) library: ç”Ÿç‰©é«”å¤–ï¼Œåè½‰éŒ„ mRNA  

  <!-- Fig. 20-6-5 -->

  ![[èŠæ›œå®‡-5.png]]

nucleic acid hybridization: nucleic acid probe  
  
  ![[èŠæ›œå®‡-6.png]]

## ==çœ‹ä¸æ‡‚==

<!-- Fig. 20-7 -->

![[èŠæ›œå®‡-7.png]]

### expression vector

![[èŠæ›œå®‡-8.png]]

### DNA Sequencing

- dideoxy chain termination method
- modified nucleotides: dideoxyribonucleotides (ddNTP)  
- each type of ddNTP æœ‰è¢å…‰æ¨™è¨˜ï¼Œto identify the nucleotide at the end of each DNA fragments
- DNA sequcnce can be read from spectrogram

<!-- Fig. 20-12 -->

![[èŠæ›œå®‡-9.png]]

è‡ªå‹•å®šåºå„€:

![[èŠæ›œå®‡-10.png]]

### Bioinformatics

![[èŠæ›œå®‡-11.png]]

homologous: åŒæº

Ortholog: ç•°ç‰©ç¨®åŒæºåŸºå› 

rodent: å›“é½’å‹•ç‰©

DNA mircroarray assays åŸºå› æ™¶ç‰‡: compare gene expression

<!--   Fig. 20-15 -->
  ![[èŠæ›œå®‡-12.png]]
  ![[èŠæ›œå®‡-13.png]]
  
  ![[èŠæ›œå®‡-14.png]]

---
```sequence
amy->ooo:fuckyou
```

# part 2

alleles: ç­‰ä½åŸºå› 

gel electrophoresis: 

- å‡è† é›»æ³³
- separate by size
  
  ![[èŠæ›œå®‡-15.png]]
  
restriction fragment analysis: 

compare 2 ä¸åŒ DNA åˆ†å­ï¼Œå¦‚ç­‰ä½åŸºå› 

![[èŠæ›œå®‡-16.png]]

## Blotting

Southern Blotting å—æ–¹å¢¨é»æ³•: åˆ©ç”¨æ¢é‡åµæ¸¬ç”±å‡è† é›»æ³³åˆ†é›¢å‡ºä¾†çš„ <font color="FF6000">DNA</font> ç‰‡æ®µï¼Œå°‹æ‰¾å«æœ‰ç‰¹å®šåºåˆ—çš„ <font color="FF6000">DNA</font> ç‰‡æ®µ
  ![[èŠæ›œå®‡-17.png]]

Northern Blotting åŒ—æ–¹å¢¨é»æ³•: åˆ©ç”¨æ¢é‡åµæ¸¬ç”±å‡è† é›»æ³³åˆ†é›¢å‡ºä¾†çš„ <font color="FF6000">mRNA</font> ç‰‡æ®µï¼Œå°‹æ‰¾å«æœ‰ç‰¹å®šåºåˆ—çš„ <font color="FF6000">mRNA</font> ç‰‡æ®µ

Western & Eastern Blotting: è›‹ç™½è³ªç›¸é—œ

## Sequencing

![[èŠæ›œå®‡-18.png]]

fold coverage: åšå¹¾æ¬¡ sequencing, expressed as 7Ã—, 8Ã—, etc.

### Illumina Sequencing Technology

![[èŠæ›œå®‡-19.png]]

deblock

Reverse transcriptase-polymerase chain reaction (RT-PCR) åè½‰éŒ„ PCR: mRNA {â†’|åè½‰éŒ„} cDNA {â†’|PCR} DNA è¤‡è£½

  ![[èŠæ›œå®‡-20.png]]

### Mircoarray vs. NGS

![[èŠæ›œå®‡-21.png]]

de novo: å¾é ­å®šåºï¼ˆ_de novo _sequencingï¼‰ï¼Œæ˜¯æŒ‡ä¸ä½¿ç”¨åƒè€ƒåºåˆ—ï¼ˆreference sequenceï¼‰ä¾†çµ„è£å®šåºçµæœ

### åˆ¤å®šåŸºå› åŠŸç”¨

æŠŠåŸºå› é—œæ‰çœ‹çœ‹æœƒæ€æ¨£

1. ç”Ÿç‰©é«”å¤–ï¼Œclone çªè®ŠåŸºå› 
2. æ›´æ”¹æˆ–å¼„æ‰é€™å€‹åŸºå› 
    - ç”¨ [RNAi (RNA interference)][RNAi]
4. å¼„å›ç”Ÿç‰©é«”

[RNAi]: #RNAi-RNA-interference

### RNAi (RNA interference)

é›™éˆ RNA {â†’|Dicer é…¶} siRNA {â†’|èˆ‡å…¶ä»–æ±è¥¿çµåˆ} RICS {â†’|é™è§£ mRNA} é˜»æ–·åŸºå› è¡¨ç¾

![[èŠæ›œå®‡-22.png]]

siRNA: small interfering RNA  
dsRNA: double-stranded RNA  
ssRNA: single-stranded RNA  
RISC: RNA-induced silencing complexï¼Œæ¯å€‹éƒ½åŒ…å«ä¸€å€‹ siRNA å’Œä¸€å€‹ä¸åŒæ–¼ Dicer çš„ RNA é…¶  
degradation: é™è§£ (åˆ†è§£)
  
exonuclease: æ ¸é…¸å¤–åˆ‡é…¶

### genetic markers

- Single nucleotide polymorphisms (SNPs, å–®æ ¸è‹·é…¸å¤šå‹æ€§)
- åŠ ä¸Šé™åˆ¶é…¶ â†’ ä¸åŒé•·åº¦çš„ DNA ç‰‡æ®µ â€” restriction fragment length polymorphism (RFLP, é™åˆ¶ç‰‡æ®µé•·åº¦å¤šå‹æ€§)
- æ¨™è¨˜æ²»ç—…ç­‰ä½åŸºå›  â†’ test genetic disorders

Single nucleotide polymorphisms (SNPs, å–®æ ¸è‹·é…¸å¤šå‹æ€§): å–®å€‹æ ¸è‹·é…¸â€”A,T,Cæˆ–Gçš„æ”¹è®Šè€Œå¼•èµ·çš„DNAåºåˆ—çš„æ”¹è®Š

restriction fragment length polymorphism (RFLP, é™åˆ¶ç‰‡æ®µé•·åº¦å¤šå‹æ€§): æ¯å€‹å€‹é«”çš„é…¶åˆ‡ä½é»ä¹‹é–“çš„è·é›¢æœƒæœ‰å·®è·ï¼Œé€™æ¨£é™åˆ¶æ€§ç‰‡æ®µçš„é•·åº¦æœ‰å€åˆ¥ï¼Œä¸åŒå€‹é«”çš„æŸå€‹æ¢å¸¶çš„ä½ç½®ä¹Ÿæœƒä¸åŒï¼ˆä¹Ÿå°±æ˜¯ã€Œå¤šæ…‹æ€§ã€ï¼‰ã€‚é€™æ¨£å°±èƒ½å¾éºå‚³æ°´å¹³ä¸Šå€åˆ†ä¸åŒå€‹é«”ã€‚RFLPä¹Ÿå¯ä»¥æ­ç¤ºä¸åŒå€‹é«”ä¹‹é–“çš„éºå‚³é—œä¿‚ï¼Œå› çˆ²å­©å­å¾çˆ¶æ¯è™•ç¹¼æ‰¿äº†æŸ“è‰²é«”ã€‚é€™ç¨®æŠ€è¡“ä¹Ÿå¯ä»¥ç”¨ä¾†åˆ¤æ–·å„å€‹ç¨®çš„ç”Ÿç‰©ä¹‹é–“çš„é—œä¿‚ã€‚

## animal cloning

Dolly sheep: from ä¹³è…ºç´°èƒç´°èƒæ ¸

 ```graphviz
 digraph{
     ç™½é¢æ¯ç¾Šä¹³æˆ¿ç´°èƒæ ¸èˆ‡é»‘é¢æ¯ç¾Šå»æ ¸åµ -> é«”å¤–åŸ¹é¤Š -> ç§»åˆ°å¦ä¸€éš»é»‘é¢æ¯ç¾Šå­å®®
 }
 ```
 
ç™½é¢æ¯ç¾Šä¹³æˆ¿ç´°èƒæ ¸+é»‘é¢æ¯ç¾Šå»æ ¸åµ â†’ é«”å¤–åŸ¹é¤Š â†’ ç§»åˆ°å¦ä¸€éš»é»‘é¢æ¯ç¾Šå­å®®

![[èŠæ›œå®‡-23.png]]

**ğŸ˜± å¤–è§€ & è¡Œç‚ºä¸æ˜¯ä¸€å®šä¸€æ¨£ (å¦‚åŒåµé›™èƒèƒ)**

- å¤§éƒ¨åˆ†è¤‡è£½èƒšèƒéƒ½ç„¡æ³•å­˜æ´»åˆ°å‡ºç”Ÿ
- å¾ˆå¤šè¡¨è§€éºå‚³è®ŠåŒ–(acetylation ä¹™é†¯åŒ– & methylation ç”²åŸºåŒ–)éƒ½è¦å…ˆè¢« reversed

ES cell: 

- embryonic stem cell èƒšèƒå¹¹ç´°èƒ
- å¯ skin cell â†’ ES cellï¼Œç¨±ç‚º iPS cell, induced pluripotent cells, èª˜å°æ€§å¤šåŠŸèƒ½å¹¹ç´°èƒ)


  ![[èŠæ›œå®‡-24.png]]

### gene therapy åŸºå› æ²»ç™‚

- æ”¹è®Šç¼ºé™·åŸºå› 

  ![[èŠæ›œå®‡-25.png]]

leukemia ç™½è¡€ç—…

å¯ä»¥è®“ host cell ä¸»å‹•åˆ†æ³Œå‡ºå«ä»–è£½ä½œçš„ protein  
â†’ ä¸éœ€ç´”åŒ–éç¨‹ï¼Œç°¡åŒ– insulin, human growth hormones, and vaccines ç­‰çš„è£½é€ 

STR: 

- short tandem repeats çŸ­åºé‡è¤‡åºåˆ—
- ä¸åŒäºº(é™¤åŒåµ)ä¹‹é–“å…·åŒ STR çš„æ©Ÿç‡æ¥µä½ â†’ ç”¨ä¾†é‘‘å®šå„ç¨®é—œä¿‚

# Part 3 åŸºå› é«”å­¸ï¼Œè›‹ç™½é«”å­¸

![[èŠæ›œå®‡-26.png]]

![[èŠæ›œå®‡-27.png]]

![[èŠæ›œå®‡-28.png]]

physical map: distance between genetic markers

haploid: å–®å€é«”

shotgun DNA sequencing (éœ°å½ˆæ§å®šåº): Randomly sequence fragments {â†’|computer} é€£çºŒ sequence
  - ä¸éœ€è¦å…¨éƒ¨ mapping ä½†å¯èƒ½å®šåˆ°ä¹‹å‰å®šéçš„

extranuclear DNA (æ ¸å¤– DNA): è‘‰ç¶ é«”ã€ç²’ç·šé«”

çœŸæ ¸åŸºå› çµ„æœ‰é‡è¤‡åºåˆ—  
  
coding region - only 2% of our genome  

![[èŠæ›œå®‡-29.png]]

![[èŠæ›œå®‡-30.png]]

phenotype: è¡¨å‹

More Complex Organisms Have Decreased Gene Density

![[èŠæ›œå®‡-31.png]]

morphological: å‹æ…‹çš„

2D gel electrophoresis äºŒç¶­é›»æ³³: æŠŠè›‹ç™½è³ªæ”¾é€² pH gradientï¼Œè›‹ç™½è³ªåˆ†å­æœƒæ ¹æ“šè‡ªå·±çš„å¸¶é›»è·‘åˆ°èƒ½è®“è‡ªå·± 0 å¸¶é›»è™•

![[èŠæ›œå®‡-32.png]]  

mass spectroscopy è³ªè­œå„€: æ¸¬é‡åˆ†è§£å‰&åˆ†è§£(ç‚ºå°æ®µ)å¾Œä¹‹ peptide â†’ åˆ¤å®š possible codon sequences that could encode such peptide

![[èŠæ›œå®‡-33.png]]

### Proteomes è›‹ç™½é«”

![[èŠæ›œå®‡-34.png]]

æ¯” genomes å¤šï¼Œå› ç‚ºï¼š

- 1 pre-mRNA â†’ many ver.
- å°ˆä¸€æ€§ (æ‡‰å°ç‰¹å®šç´°èƒã€ç’°å¢ƒ)
- modification
    - phosphorylation (ç£·é…¸åŒ–), methylation(ç”²åŸºåŒ–), acetylation (ishi åŒ–)

![[èŠæ›œå®‡-35.png]]

# part 4 ç´°èƒé€±æœŸ

æ­£å¸¸ç´°èƒåˆ†è£‚ 50 æ¬¡å¾Œæ­»äº¡å› ç‚º <u>ç«¯ç²’ (tolemere)</u> åœ¨ DNA è¤‡è£½æ™‚ç¸®çŸ­

apoptosis ç´°èƒè‡ªå™¬: èƒšèƒç™¼è‚²éç¨‹ or å—æç´°èƒ

ç™Œç´°èƒä¸ç†ä¸€èˆ¬ç´°èƒé€±æœŸ

![[èŠæ›œå®‡-36.png]]

![[èŠæ›œå®‡-37.png]]

![[èŠæ›œå®‡-38.png]]

mitosis: æœ‰çµ²åˆ†è£‚

### å…©ç¨®è›‹ç™½ involved

- cyclin  
  : ç´°èƒé€±æœŸè›‹ç™½
- Cdk, cyclin-dependent kinases
  : controlled by cyclin so æœƒæ³¢å‹•

MPF, maturation-promoting factor: - cyclin-Cdk complex

$G_2$ â†’ M

![[èŠæ›œå®‡-39.png]]

![[èŠæ›œå®‡-40.png]]

platelet  : è¡€å°æ¿

signs at checkpoint:

- internal signs å¦‚æ±è¥¿é‚„æ²’æ¥å¥½
    e.g. kinetochores (è‘—çµ²ç²’) not attached to spindle microtubules send a molecular signal that delays anaphase
- external signs å¦‚ä¿ƒé€²åˆ†åŒ–çš„è›‹ç™½è³ª
  e.g. PDGF ä¿ƒé€²åˆ†åŒ– fibrolast cell
![[èŠæ›œå®‡-41.png]]

![[èŠæ›œå®‡-42.png]]

## ç™Œç—‡

### è…«ç˜¤ tumor

- benign tumor è‰¯æ€§è…«ç˜¤: æœ‰è†œã€éä¾µå…¥æ€§ã€ä¸è½‰ç§»(metastases)
- malignant tumor æƒ¡æ€§è…«ç˜¤: ç„¡è†œ (æ•£è½)ã€ä¾µå…¥å‘¨é­çµ„ç¹”ã€æœƒè½‰ç§» 

### p53 gene

p53 è›‹ç™½åœ¨ G~1~ æª¢æŸ¥é»åµæ¸¬åˆ°å—æ DNA â†’ åœæ­¢åˆ†è£‚  
ç„¡æ³•ä¿®å¾© â†’ ç´°èƒè‡ªå™¬  

p53 å¤±å»åŠŸèƒ½ â†’ å—æç´°èƒç¹¼çºŒåˆ†è£‚ â†’ å¯èƒ½ç™Œè®Š
  
 ![[èŠæ›œå®‡-43.png]]
 
 carcinogens : è‡´ç™Œ

# Part 5 çªè®Š

### çªè®Šæ¨¡å¼

1. change base sequence
2. add/remove nucleotide(s)

![[èŠæ›œå®‡-44.png]]

### çªè®Šè¡¨è§€å½¢å¼

1. silent/neutral mutation ç·˜é»˜çªè®Š
    - ä¸æ”¹è®ŠèƒºåŸºé…¸åºåˆ—
    - ![[èŠæ›œå®‡-45.png]]
2. missense mutation éŒ¯ç¾©çªè®Š
    - æ”¹è®Š==ä¸€å€‹==èƒºåŸºé…¸ (in å¤šè‚½éˆ)
    - è‹¥æ”¹è®Šçš„èƒºåŸºé…¸åŒ–å­¸æ€§è³ªç›¸ä¼¼ â†’ neutral
    - e.g. sickle-cell anemia é®åˆ€å‹è²§è¡€ç—‡
    - ![[èŠæ›œå®‡-46.png]]
3. nonsense mutation ç„¡éŒ¯ç¾©çªè®Š
    - normal codon â†’ start/termination codon  
    - è¢«æˆªæ–·çš„ polypeptide
    ![[èŠæ›œå®‡-47.png]]
4. frameshift mutation ç§»ç¢¼çªè®Š
    - åŠ æ¸›é 3 çš„å€æ•¸çš„ nucleotides 
    (become another amino acid sequence if 3:star:)

### coding sequences å¤–çš„åŸºå› çªè®Š

- **Promoter**
    - Up promoter mutations or down promoter mutations
- **Transcriptional response element/operator site**
    - May alter regulation of transcription
- **Splice junctions**
    - Mutations at the boundaries between introns and exons can prevent proper splicing
- **Translational response elements**
    - May prevent proper translational regulation

### germ-line mutation (ç”Ÿæ®–ç³»çªè®Š) or somatic cell mutation (é«”ç´°èƒçªè®Š)

![[èŠæ›œå®‡-48.png]]

### Spontaneous matation or induced mutations

![[èŠæ›œå®‡-49.png]]

Spontaneous: è‡ªç„¶éŒ¯èª¤  

induced: ç’°å¢ƒå› ç´ (ç‰©ç† or åŒ–å­¸ mutagen)  

![[èŠæ›œå®‡-50.png]]

mutagen: 

- disrupt pairing
- modify nucleotide structure
- ç”¨é¹¼åŸºé¡ä¼¼ç‰©
- çƒ·åŒ–é¹¼åŸº

![[èŠæ›œå®‡-51.png]]

å¹²æ“¾è¤‡è£½

![[èŠæ›œå®‡-52.png]]
  
  - æ¸¸é›¢è¼»å°„
      - å¼·å¤§ç©¿é€åŠ›
      - X ray & Î³ ray
      - delete base (1 or both DNA strand)
  - éæ¸¸é›¢è¼»å°„
      - åªèƒ½ç©¿é€è¡¨é¢
      - UV ray
      - é€ æˆ thymine dimer çš„ gap or éŒ¯èª¤ base é…å°

      ![[èŠæ›œå®‡-53.png]]

### å®‰å§†æ°å¯¦é©— Ames test 

-  ç”¨å› ç‚ºçªè®Šè€Œç„¡æ³•åˆæˆ histidine(çµ„æ°¨é…¸) çš„ Salmonella typhimurium(æ²™é–€æ°èŒ)
- è¦æœ‰ histidine, bacteria æ‰æœƒç”Ÿé•·

ä¸€ç›¤ä¸åŠ  mutagen ä¸€ç›¤åŠ  

![[èŠæ›œå®‡-54.png]]

åŠ çš„é‚£ç›¤å¾ˆå¿«å°±çªè®Š

### DNA repair

- direct repair
    - enzyme removes modification then Photoreactivation(å…‰æ´»åŒ–) repair
    - ![[èŠæ›œå®‡-55.png]]
- å–ä»£ DNA strand section (è¼ƒå¸¸è¦‹)
    - base excision(åˆ‡é™¤) repair
    - ![[èŠæ›œå®‡-56.png]]
    - nucleotide excision repair (æœ€å¸¸è¦‹çš„)
	    - ![[èŠæ›œå®‡-57.png]]
    - methyl-directed mismatch (base é…å°éŒ¯èª¤) repair
	    - ![[èŠæ›œå®‡-58.png]]
    - double strand break repair

90% ç™Œç—‡èˆ‡éºå‚³ç„¡é—œ

carcinogens: è‡´ç™Œç‰©

### ç™Œç—‡æµç¨‹

```graphviz
digraph{
    ä¸€å€‹ç´°èƒ -> çªè®Š -> overgrow -> benign_or_precancerous_tumor -> malignant -> invasive -> metastatic
}
```

oncogene è‡´ç™ŒåŸºå›   
tummor-suppressor gene æŠ‘ç™ŒåŸºå›   
mutation å¯èƒ½é€ æˆä¸Šå…©åŸºå›  overactive/eliminated

oncogene å¯ä¸€ç›´ keep æ˜¯å¦ç”Ÿé•· signal on

![[èŠæ›œå®‡-59.png]]

å·¦: è‡ªå·±åš signalï¼›å³: æŠ‘åˆ¶è›‹ç™½çš„è½‰è­¯å› å­ä¸è¦‹

proto-oncogene: oncogene that is originally a normal gene (mutation)

![[èŠæ›œå®‡-60.png]]

- missense mutation éŒ¯ç¾©çªè®Šï¼šä¸€å€‹èƒºåŸºé…¸æ”¹è®Š)
	- ![[èŠæ›œå®‡-61.png]]
	- ![[èŠæ›œå®‡-62.png]]
- gene amplification åŸºå› æ”¾å¤§ï¼šé‡è¤‡è¤‡è£½åŸºå›  
	- ![[èŠæ›œå®‡-63.png]]
- Chromosomal translocation æŸ“è‰²é«”è½‰ä½ï¼š2 ä¸åŒæŸ“è‰²é«”éŒ¯èª¤çµåˆ
	- ![[èŠæ›œå®‡-64.png]]
	- ![[èŠæ›œå®‡-65.png]]
- Retroviral insertions åè½‰éŒ„ç—…æ¯’æ’å…¥ï¼š
  - proto-oncogene å‰›å¥½è¢« overexpressed â†’ cancer
  - ![[èŠæ›œå®‡-66.png]]
  - or virus carries oncogene

viral: ç—…æ¯’çš„

### æŠ‘ç™ŒåŸºå›  tumor-suppressor gene 

1. checkpoint protein ï¼ åœ¨ç´°èƒé€±æœŸä¸­æª¢æŸ¥ç‹€æ³: 
	- [cyclin & Cdk åƒèˆ‡ç´°èƒé€±æœŸ](#å…©ç¨®è›‹ç™½-involved)
	- can stop activated cyclin-cdk complex (which peaks in M æœŸ i.e. ç´°èƒåˆ†è£‚æœŸ)
	- 50% äººé¡ç™Œç—‡èˆ‡ p53 gene ç¼ºé™·æœ‰é—œ
	- æœ‰ checkpoint gene ç¼ºé™·ä¸æœƒæ€æ¨£ï¼Œä½†è¼ƒå®¹æ˜“çš„ç™Œç—‡
1. Rb gene ï¼ æŠ‘åˆ¶ç´°èƒåˆ†è£‚ (é˜²æ­¢éåº¦åˆ†è£‚): 
	- è² å›é¥‹ E2F (who helps G~1~ â†’ S)
	- binds E2F â†’ æŠ‘åˆ¶
	- ç¼ºé™· â†’ E2F always active
	- ![[èŠæ›œå®‡-67.png]]

### è¦–ç¶²è†œæ¯ç´°èƒç˜¤ retinoblastoma 

è§¸ç™¼æ¢ä»¶ï¼šretina ç´°èƒå…§ 2 å€‹çªè®Š  
äººæœ‰ä¸€å° Rb gene from é›™è¦ª  
æ­£å¸¸ geneï¼šunlikely to have 2 mutation in same cell  
å·²æœ‰ä¸€å€‹ mutant gene from éºå‚³ï¼šlikely to occur early
 
å¤±å»æŠ‘ç™ŒåŸºå› ï¼šmutationã€å¤±å»æŸ“è‰²é«”ã€ä¸æ­£å¸¸ CpG ç”²åŸºåŒ– near promoter

![[èŠæ›œå®‡-68.png]]

![[èŠæ›œå®‡-69.png]]

### ç™Œç—‡æ²»ç™‚

![[èŠæ›œå®‡-70.png]]

![[èŠæ›œå®‡-71.png]]
